All posts tagged mdt
Medtronic Neuromodulation Business Gets FDA Warning Letter
Medtronic Inc.’s (MDT) business for neuromodulation devices recently received a Food and Drug Administration warning letter related mainly to the company’s processes for handling complaints, the medical-device maker disclosed Tuesday. “We are working with the FDA to quickly resolve the …
Medtronic Granted CE Mark
Medtronic has been rewarded with a CE Mark for a new non-surgical procedure it has devised that is suitable for young children suffering from life-threatening curvature of the
Medtronic receives notification that U.S. Department Of Justice and U.S. Attorney’s office have closed their investigation of activities relating to Infuse® bone graft
MINNEAPOLIS – MAY 16, 2012 – Medtronic, Inc. (NYSE: MDT) today announced it has been notified by the U.S. Department of Justice (DOJ) and the Office of the United States Attorney for the
Medtronic to Ramp-Up Device Inspections
Medtronic, Inc., the world's largest stand-alone medical device maker, is no longer going to rely on irregular reports from doctors or patients to monitor its medical devices. Instead
Medtronic Announces Launch of the POWEREASE(TM) System
MEMPHIS, Tenn., Apr 16, 2012 (BUSINESS WIRE) -- Medtronic, Inc. MDT -0.05% today announced the initiation of its launch of the POWEREASE(TM) System, an innovative system of electronic instruments
More shareholders sue Medtronic over Infuse claims
Medtronic (NYSE:MDT) found itself at the center of another shareholder lawsuit accusing it of artificially boosting its stock price and forcing the company
Medical device tax to cost Medtronic about $125M to $175M annually
It appears that Medtronic (NYSE: MDT) is assuming that all the efforts to repeal the medical device taxare not going to amount to much and that companies will have
Could Black Bear Blood Replace Infuse?
Black bear blood sounds like a bizarre source for a bone growth enhancer. However, Aursos, Inc. a Michigan-based company, is counting on a biomarker in the blood of
Medtronic indicates it’s considering selling its spine unit
Medtronic debuts new spinal fusion procedure
Medtronic Inc. has introduced a new spinal surgery product which the company says improves on current methods of spinal fusion surgery. The product, called MAST MIDLF, uses smaller incisions
Medtronic: Dividend Stock Analysis
JURY FINDS NUVASIVE INFRINGES 3 MEDTRONIC PATENTS, AWARDS MEDTRONIC $101.2M IN DAMAGES; MAINTAIN HOLD AND $22.50 PT
JURY FINDS NUVASIVE INFRINGES 3 MEDTRONIC PATENTS, AWARDS MEDTRONIC $101.2M IN DAMAGES; MAINTAIN HOLD AND $22.50 PT
Click Here for the Entire Article From Canaccord
NuVasive Announces Jury Verdict in Patent Case
NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today that a jury in the U.S.
Jury Awards Medtronic $101 Million In Patent Suit Against NuVasive
MEMPHIS, TENN. – Sept. 20, 2011 – Medtronic, Inc. (NYSE: MDT) announced today that a jury in the United States District Court of the Southern District of California in San





